Hülya Çetin Tunçez

Dr. Hülya Çetin Tunçez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Cureus
Verified
Journal Article
Open access
MTMahmut Tunçez
Mahmut Tunçez
IAIhsan Akan
Ihsan Akan
FSFırat Seyfettinoğlu
Fırat Seyfettinoğlu
HTHülya Çetin Tunçez
Hülya Çetin Tunçez
BMBerna Dirim Mete
Berna Dirim Mete
CKCemal Kazımoğlu
Cemal Kazımoğlu
A gold standard classification for the treatment of tibial plateau fractures with soft tissue injury has not been established yet. This study aimed to evaluate the usability of a novel modified classification that can provide preoperative information to the surgeon about soft tissue injuries in tibial plateau fractures. A total of 36 patients with tibial plateau fractures were included in the study. Patients’ age, gender, and affected sides were recorded. Injuries to the medial meniscus, lateral meniscus, anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, and lateral collateral ligament were examined with preoperative magnetic resonance imaging. Soft tissue injuries were arranged according to the novel modified classification based on the Schatzker classification. The mean age of the study participants was 45 (19-76) years; 72% of the patients were men and 28% were women. Moreover, 44% and 56% of the patients had broken the right and left tibial plateaus, respectively. At least one soft tissue injury was detected in 29 (81%) patients. In 14 (39%) patients, two or more soft tissue injuries were observed. All patients were arranged according to the novel modified classification regarding ligament and meniscus injuries. With this novel modified classification system, we think that having better information about the preoperative condition of the soft tissue injuries can change the surgical strategy in patients with tibial plateau fractures.

1 January 2024 in Journal of the Belgian Society of Radiology
Verified
Journal Article
Open access
PDF file
ABAhmet Bozer
Ahmet Bozer
HTHülya Çetin Tunçez
Hülya Çetin Tunçez
TKTuğçe Doğa Kul
Tuğçe Doğa Kul
AAAsuman Argon
Asuman Argon
Objectives: This study aimed to investigate ultrasound (US) features of thyroid nodules categorized as nondiagnostic (ND) and atypia of undetermined significance (AUS) according to the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) and their potential implications for clinical management. Materials and Methods: A retrospective study was conducted on patients who underwent thyroid nodules FNAC between 2019 and 2023. Nodules falling into the ND and AUS categories were analyzed for US features, nodule size, composition, echogenicity, shape, margin, echogenic foci, the distribution of the American College of Radiology’s Thyroid Imaging Reporting and Data System (ACR TI-RADS) categories, and other parameters. The study included a total of 1,199 patients and 1,252 nodules (ND: 1110; AUS: 142). Results: No significant differences in age, gender, nodule features, echogenicity, shape, margin, echogenic foci, TI-RADS scores, localization, number of nodules, or thyroid parenchymal disease presence were found between the ND and AUS categories (p > 0.05). Also, no statistically significant difference in nodule size (<10 mm vs. ≥10 mm) existed between the ND and AUS categories (p = 0.475). Both showed predominantly solid composition and hyperechoic/isoechoic echogenicity. High proportions of TI-RADS 4 nodules were observed in both groups, with 727 (65.5%) in ND and 95 (66.9%) in AUS. Conclusion: This study found no statistically significant differences in US characteristics between the ND and AUS categories, indicating potential similarities in their radiological appearances. Also, no significant difference in nodule size (<10 mm and ≥10 mm) was observed between these categories. Clinical management should consider further investigations, including repeat FNAC, due to the diagnostic challenges and malignancy risk in both categories.

1 January 2025 in Magnetic Resonance in Medical Sciences
Verified
Journal Article
Open access
PDF file
ABAhmet Bozer
Ahmet Bozer
CYCengiz Yılmaz
Cengiz Yılmaz
HTHülya Çetin Tunçez
Hülya Çetin Tunçez
DÇDemet Kocatepe Çavdar
Demet Kocatepe Çavdar
ZAZehra Hilal Adıbelli
Zehra Hilal Adıbelli
Purpose: This study aims to evaluate the predictive value of MRI features for pathologic complete response (pCR) and survival outcomes in patients with breast cancer (BC) undergoing neoadjuvant chemotherapy (NAC).Methods: A retrospective analysis was conducted on 168 BC patients treated with NAC between 2018 and 2022. Pre-NAC breast MRI scans were evaluated for enhancement patterns, time-intensity curve (TIC), peritumoral edema, and background enhancement. Both pre- and post-NAC MRIs were assessed for Epeak %, mean apparent diffusion coefficient (ADC) value, and ADC ratio (mean ADC of lesion/contralateral normal breast parenchyma). Survival outcomes were analyzed using Kaplan−Meier and Cox regression models.Results: pCR was achieved in 34% of patients. MRI demonstrated a sensitivity of 74% and a specificity of 86% in predicting pCR, with an overall accuracy of 82%. The post-NAC percentage of initial peak enhancement (Epeak) was significantly lower in the pCR group (P < 0.001). Multivariate analysis identified a pre-NAC Epeak ≤ 96 (hazard ratio [HR]: 6.26, P < 0.001) and a post-NAC Epeak > 188 (HR: 18.40, P < 0.001) as independent risk factors for disease-free survival. Additionally, a lower pre-NAC ADC ratio (≤0.65) was associated with poorer overall survival (HR: 2.8, P: 0.041). Pre-NAC peritumoral edema, background enhancement, and TIC were not significant predictors of survival outcomes.Conclusion: MRI features, including Epeak % and ADC ratio, are important predictors of pCR and survival outcomes in BC patients undergoing NAC. Incorporating these biomarkers into clinical practice may improve treatment planning and optimize patient outcomes.

17 July 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
HTHülya Çetin Tunçez
Hülya Çetin Tunçez
MBMerve Gürsoy Bulut
Merve Gürsoy Bulut
ZAZehra Hilal Adıbelli
Zehra Hilal Adıbelli
ABAhmet Bozer
Ahmet Bozer
BKBülent Ahmet Kart
Bülent Ahmet Kart
DÇDemet Kocatepe Çavdar
Demet Kocatepe Çavdar
Background/Objectives: Thirty to fifty percent of ductal carcinoma in situ (DCIS) cases are high-grade and at risk of progressing to invasive carcinoma. The most important treatment-related risk factor for recurrence is the presence of residual DCIS. The aim of our study was to evaluate the relationship between size and imaging features on preoperative mammography and magnetic resonance imaging (MRI) and histopathological size and nuclear grade in patients with pure DCIS. Methods: Between 2015 and 2023, 90 patients who underwent surgery for DCIS, had no microinvasive/invasive component, and underwent a preoperative mammography and MRI were included in this study. Results: DCIS was detected in 91.1% of patients using mammography and 95.5% using MRI. Microcalcifications (MCs) were most common in mammography (85.4%). Thin pleomorphic and thin linear branching MCs were detected in 42% of high-grade DCIS, while amorphous (42%) MCs were most common in low-grade DCIS. In low-grade DCIS cases, a grouped distribution of MCs was observed most commonly (69%). There was a statistically significant difference between DCIS groups in terms of MC morphology and distribution (p = 0.043, p = 0.005, respectively). Diffusion restriction on MRI was associated with high-grade DCIS (p = 0.043). The tumor size was greater than the pathological size and correlated poorly with mammography and moderately with MRI. Conclusions: Compared to mammography, MRI is more effective in detecting and estimating the size of DCIS. Both methods overestimate tumor size compared to histopathological size. The nuclear grade is associated with a poor prognosis and local recurrence in DCIS.

23 April 2026 in European Journal of Therapeutics
Verified
Journal Article
Open access
PDF file
HTHülya Çetin Tunçez
Hülya Çetin Tunçez
MCMehdi Can
Mehdi Can
ZAZehra Hilal Adıbelli
Zehra Hilal Adıbelli
DÇDemet Kocatepe Çavdar
Demet Kocatepe Çavdar
Objective: This study aimed to explore the association between dynamic breast MRI features of non-mass enhancement (NME) and clinical as well as histopathological outcomes, and to compare the imaging characteristics of mass-associated NME with their pathological correlates. Methods: Breast MRI examinations performed at our institution between January 2019 and October 2023 were retrospectively reviewed. Patients displaying NME with either histopathological confirmation or a minimum of 24 months of MRI follow-up were included. Exclusion criteria comprised prior neoadjuvant chemotherapy, lack of pathology or adequate follow-up, and pregnancy or lactation. NME findings were assessed using the 5th edition BI-RADS MRI lexicon, and lesions adjacent to a mass were categorized separately. Results: Seventy-seven women met the inclusion criteria; 44 (57.1%) NMEs were malignant and 33 (42.9%) were benign. Patients with malignant NME were significantly older. Malignant lesions more frequently demonstrated plateau or washout enhancement kinetics, whereas persistent enhancement predominated in benign cases. Diffusion restriction was substantially more common in malignant lesions, which also showed significantly lower ADC values. More than half of the NMEs (54.5%) were mass-associated, and the vast majority of these (83.3%) were malignant. Tumor size and histopathological subtype did not significantly differ between malignant mass-associated and non–mass-associated NME. Conclusion: Advanced age, segmental distribution, clumped or clustered-ring enhancement patterns, diffusion restriction, and reduced ADC values were strongly associated with malignant NME. NME contiguous with a mass showed markedly elevated malignancy rates and should be carefully considered during preoperative planning.

25 April 2023
Verified
Book
Open access
PDF file
ÇEÇağrı Erdim
Çağrı Erdim
EBEzel Yaltirik Bilgin
Ezel Yaltirik Bilgin
SCSıla Özgürgün Cankaya
Sıla Özgürgün Cankaya
FAFeryal Kocamaz Akcay
Feryal Kocamaz Akcay
MTMehmet Turmak
Mehmet Turmak
BKBedia Kesimal
Bedia Kesimal
Pediatrik Girişimsel Radyolojiye Genel Bakış Çağrı ERDİM Girişimsel İşlemler Öncesi Hasta Değerlendirme Ezel YALTIRIK BİLGİN Girişimsel İşlem Öncesi Görüntüleme Teknikleri Sıla ÖZGÜRGÜN CANKAYA Pediatrik Girişimsel Radyolojide Anestezi Feryal KORKMAZ AKÇAY Baş ve Boyun Vasküler Anatomisi Mehmet TURMAK Baş-Boyun Vasküler Anomalileri Hüseyin Gökhan YAVAŞ Muhammed ALPASLAN Serebral Anjiyografi Teknik ve Uygulamalar Velihan ÇAYHAN Serebral Endovasküler Tedaviler Bige SAYIN Karotis Ve Vertebral Arter Girişimleri Emre ALP Baş Boyun Vasküler Tümörler Ali DABLAN Spinal Vasküler Anatomi ve Varyasyonlar Hamza ÖZER Pediatrik Spinal Endovasküler Girişimler Bige SAYIN Periferik Arteriyel Anatomi Betül AKDAL DÖLEK Pediatrik Anjıiografiye Genel Bakış Husam VEHBİ Pulmoner Vasküler Malformasyonlar Mehtap OKTAY Pulmoner Arter Girişimleri Mehmet CİNGÖZ Torasik Aorta Girişimsel İşlemleri Gökçe KAŞ İbrahim ECE Abdominal Aorta ve Pelvik Arter Girişimleri Erbil ARIK Gürkan DANIŞAN Renal Arter Girişimleri Muhammet Kürşat ŞİMŞEK İsmail DİLEK Üst Ekstremite Arteriyel Girişimleri Hülya ÇETİN TUNÇEZ Alt Ekstremite Arteriyel Girişimleri Ahmet BAYRAK İntravasküler Yabancı Cisim Çıkarılması İsmail DİLEK Muhammet Kürşat ŞİMŞEK Periferik Venöz Anatomi Seçil GÜNDOĞDU Pediyatrik Venografi’ye Genel Bakış Sevgi DEMİRÖZ TAŞOLAR Periferik Vasküler Malformasyonlar Mehmet TURMAK Muhammed TEKİNHATUN Pediatrik Santral Venöz Girişimler Çağrı DAMAR Boyun ve Üst Ekstremite Venöz Girişimleri Merve HOROZ DÖNMEZ Lenfanjiografi ve Duktus Torasikus Embolizasyonu Samet GENEZ Portal ve Hepatik Venöz Girişimler, Konjenital Portosistemik Şant Tanı ve Tedavisi Ahmet BAYRAK Görüntüleme Eşliğinde Perkütan Biyopsiler Emre ALP Plevral Efüzyon ve Ampiyem Tedavisi Betül AKDAL DÖLEK Perkütan Apse ve Sıvı Drenajları Mustafa REŞORLU Fırathan SARIALTIN Perkütan Kist Hidatik Tedavisi Gülsüm Kübra BAHADIR Perkütan Gastrointestinal Girişimler Gülsüm Kübra BAHADIR Perkütan Biliyer Girişimler Mahmut DEMİRCİ Perkütan Üriner Sistem Girişimleri Mustafa YILDIRIM Hakan ARTAŞ Ahmet Kürşad POYRAZ Çocuklarda Perkütan Basit Renal Kist Tedavisi ve Perkütan Nefrolitotomi Gülşah BAYRAM ILIKAN Görüntüleme Eşliğinde Meme Girişimleri Seçil GÜNDOĞDU Pediatrik Kas İskelet Sistemi Girişimsel İşlemleri Kadir Han ALVER Görüntüleme Eşliğinde Tümör Ablasyonu Temel Prensipleri Uğur KESİMAL Retinoblastomda İntraarteriyel Kemoterapi Bedia KESİMAL Uğur KESİMAL